As Determinações das judicializações dos medicamentos no SUS: entre a efetivação do direito à saúde e os interesses da indústria farmacêutica sob o fundo público

Abstract

The Course Conclusion Work (TCC) presented brings as its theme the determinations of the legalization of medicines in the SUS. The research aims to analyze the factors that contribute to the process of legalization of health for medicines in Brazil and the contradiction that involves the realization of the right to health and the capture of public funds by the pharmaceutical industry. The study was developed through a bibliographical and documentary research that resulted in the expansion of knowledge about several aspects that involve the judicialization of health, mainly, the interest of the pharmaceutical industry and the compulsory licensing of patents. It is concluded that the legalization of medicines in the SUS is a contradictory phenomenon, it is configured as an instrument that contributes to the realization of the right to health, representing the defense of social rights, while it becomes a field of action for the industry pharmaceutical that aims to capture the public health fund to meet their economic interests, representing capitalist interests in the context of public health.